Ken Griffin Organogenesis Holdings Inc. Transaction History

Citadel Advisors LLC

$483 Billion
Q2 2024

A detailed history of Ken Griffin (Citadel Advisors LLC) transactions in Organogenesis Holdings Inc. stock. As of the latest transaction made, Citadel Advisors LLC holds 3,800 shares of ORGO stock, worth $11,362. This represents 0.0% of its overall portfolio holdings.

Number of Shares

3,800

Previous 10,400 63.46%

Holding current value

$11,362

Previous $29,000 65.52%

% of portfolio

0.0%

Previous 0.0%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$2.28 - $3.03 $99,667 - $132,453	-43,714 Reduced 19.18%	184,217 $515,000
Q1 2024 May 15, 2024	SELL	$2.61 - $4.49 $602,547 - $1.04 Million	-230,861 Reduced 50.32%	227,931 $647,000
Q4 2023 Feb 14, 2024	SELL	$1.97 - $4.21 $315,164 - $673,524	-159,982 Reduced 25.85%	458,792 $1.88 Million
Q3 2023 Nov 14, 2023	SELL	$2.34 - $4.43 $2.91 Million - $5.5 Million	-1,242,416 Reduced 66.75%	618,774 $1.97 Million
Q2 2023 Aug 14, 2023	SELL	$1.9 - $4.3 $1.31 Million - $2.97 Million	-690,700 Reduced 27.07%	1,861,190 $6.18 Million
Q1 2023 May 15, 2023	BUY	$1.89 - $2.93 $3.55 Million - $5.5 Million	1,876,307 Added 277.73%	2,551,890 $5.44 Million
Q4 2022 Feb 14, 2023	SELL	$2.48 - $3.43 $1.12 Million - $1.55 Million	-451,546 Reduced 40.06%	675,583 $1.82 Million
Q3 2022 Nov 14, 2022	BUY	$3.14 - $6.43 $1.2 Million - $2.47 Million	383,714 Added 51.62%	1,127,129 $3.65 Million
Q2 2022 Aug 15, 2022	SELL	$4.74 - $8.15 $207,995 - $357,630	-43,881 Reduced 5.57%	743,415 $3.63 Million
Q1 2022 May 16, 2022	BUY	$6.47 - $9.57 $3.76 Million - $5.56 Million	580,717 Added 281.11%	787,296 $6 Million
Q4 2021 Feb 14, 2022	SELL	$9.02 - $13.5 $2.03 Million - $3.04 Million	-225,522 Reduced 52.19%	206,579 $1.91 Million
Q3 2021 Nov 15, 2021	SELL	$13.71 - $17.18 $2.17 Million - $2.72 Million	-158,456 Reduced 26.83%	432,101 $6.15 Million
Q2 2021 Aug 16, 2021	BUY	$14.92 - $23.23 $1.18 Million - $1.83 Million	78,946 Added 15.43%	590,557 $9.82 Million
Q1 2021 May 17, 2021	BUY	$7.33 - $21.06 $2.82 Million - $8.11 Million	385,068 Added 304.3%	511,611 $9.32 Million
Q4 2020 Feb 16, 2021	BUY	$3.63 - $7.53 $459,351 - $952,868	126,543 New	126,543 $953,000
Q2 2020 Aug 14, 2020	SELL	$2.86 - $4.61 $67,824 - $109,326	-23,715 Closed	0 $0
Q1 2020 May 15, 2020	SELL	$2.92 - $5.31 $114,501 - $208,221	-39,213 Reduced 62.31%	23,715 $77,000
Q4 2019 Feb 14, 2020	BUY	$4.7 - $8.11 $203,260 - $350,733	43,247 Added 219.74%	62,928 $303,000
Q3 2019 Nov 14, 2019	SELL	$3.57 - $8.09 $23,672 - $53,644	-6,631 Reduced 25.2%	19,681 $129,000
Q2 2019 Aug 14, 2019	BUY	$6.58 - $8.69 $173,132 - $228,651	26,312 New	26,312 $200,000

Others Institutions Holding ORGO

# of Institutions

122

Shares Held

60.5M

Call Options Held

28.8K

Put Options Held

27.9K

View Full List

About Organogenesis Holdings Inc.

Ticker ORGO
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 130,888,000
Market Cap $391M
Description
Organogenesis Holdings Inc., a regenerative medicine company develops, manufactures, and commercializes solutions for the advanced wound care, and surgical and sports medicine markets in the United States. The company's advanced wound care products include Affinity, an amniotic membrane wound covering in which viable cells growth factors/cytokin...

More about ORGO

Track Ken Griffin's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.

Account